DRDGOLD scheme buys 914,973 shares for R38.9M
The Scheme has a direct beneficial interest in the shares, and the acquisitions were executed on-market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DRDGOLD Limited reported acquisitions of its ordinary shares on behalf of its equity settled long-term incentive scheme: 500,000 shares on October 20, 2026, at a volume weighted average price of R41.4068 per share, with a stated value of R20,703,400.00; and 914,973 shares on October 21, 2026, at R42.5166 per share, with a stated value of R38,901,541.05. The Scheme has a direct beneficial interest in the shares, and the acquisitions were executed on-market. Clearance to deal was obtained under the JSE Listings Requirements.
Key Figures
Key Terms
equity settled long-term incentive scheme financial
direct beneficial interest regulatory
clearance to deal regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.